Products for Research Use Only

Haloperidol

CAT: 0013-GTR19162141-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19162141-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Haloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function. Besides, Haloperidol has shown about 50-fold potency than chiorpromazine, the other antipsychotic drug. Haloperidol has shown beneficial effects in the treatment of delusions and hallucinations. These effects are mainly achieved through blockage of dopamine receptors in the mesocortex and limbic system. (In Vivo) :Haloperidol (1 mg) intra-arterially attenuates the dopamine-induced pancreatic secretion. Haloperidol (3 mg) completely inhibits the action of 10 μg of dopamine in the pancreas of the dogs. Haloperidol (10 mg/kg) as well as chlorpromazine (CPZ, 15 mg/kg) blocks mescaline-induced altered behavior within 7 to 10 minutes when injected into the mice 45 minutes after 50 mg/kg (2 μc) of mescaline. Haloperidol has no effect on mescaline disappearance.
CAS Number
52-86-8
Product Name Alternative
McN-JR 1625 | NSC 170973 | NSC 615296 | R 1625
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 8 mg/mL (21.28 mM) ; DMSO: 75 mg/mL (199.54 mM)
Smiles
C1CN (CCC1 (C2=CC=C (C=C2) Cl) O) CCCC (=O) C3=CC=C (C=C3) F
Molecular Formula
C21H23ClFNO2
Molecular Weight
375.87
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4-[4- (4-chlorophenyl) -4-hydroxypiperidin-1-yl]-1- (4-fluorophenyl) butan-1-one

Alternative Products